Extensive Small Cell Lung Cancer
4 clinical trials · Condition
◉ Watch Extensive Small Cell Lung Cancer
| Record | Firm | Date |
|---|---|---|
| A Phase II Study of QL1706 With Anti-angiogenesis Therapy and Chemotherapy in Extensive-stage Small Cell Lung Cancer. (NCT07083375) | Zhijie Wang | 2025-08-01 |
| Adebelizumab Combined With Chemotherapy and Radiotherapy Treat ES-SCLC (NCT06125041) | Qianfoshan Hospital | 2023-10-30 |
| A Phase II Clinical Study of Cadonilimab in Treatment-naïve or Relapsed Extensive Small Cell Lung Cancer (NCT06406673) | Henan Cancer Hospital | 2023-10-16 |
| A Study of TQB2450 or Placebo Combined With Anlotinib, Etoposide and Carboplatin Versus Etoposide and Carboplatin in Subjects With Extensive Small Cell Lung Cancer (ETER701) (NCT04234607) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2020-01-01 |
Track Extensive Small Cell Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.